Long-term use of carglumic acid in methylmalonic aciduria, propionic aciduria and isovaleric aciduria in Italy: a qualitative survey.
A Burlina, I Bettocchi, G Biasucci...
https://pubmed.ncbi.nlm.nih.gov/35916811/Actively Recruiting
Led by RECORDATI GROUP · Updated on 2024-02-05
95
Participants Needed
32
Research Sites
239 weeks
Total Duration
Researchers are conducting a prospective observational study to understand the long-term management of propionic aciduria PA and methylmalonic aciduria MMA using maintenance therapy with carglumic acid NCG. This study collects detailed data on treatment characteristics, clinical outcomes, and healthcare use among patients who have been treated with carglumic acid for more than six months. Additionally, qualitative interviews with adult patients and caregivers gather insights about the disease and treatment burden. The study includes up to 85 patients diagnosed with MMA or PA from several European countries who have used carglumic acid for at least six months. Data is collected at baseline, 12, 18, 36, and 54 months to track changes over time. Participants or their caregivers may also take part in one-on-one phone interviews to discuss symptoms, treatment experiences, preferences, and satisfaction. During the study, researchers review medical charts and record demographic and treatment history information through a web-based system. The interviews are audio-recorded, transcribed, and analyzed to identify patient experiences and treatment impacts. The main outcome measured is the change in the number and duration of metabolic decompensation events over 54 months, along with secondary outcomes like healthcare use, caregiver burden, satisfaction, and maintenance dosage. Participants remain involved for up to 54 months with ongoing data collection and interviews.
CONDITIONS
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
V
Vincenzo Giordano, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
RECORDATI GROUP
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) to review eligibility and consent
Duration - 54 months
Participants who have been treated with carglumic acid for organic acidemia are observed over time through medical chart reviews to track health status and treatment outcomes.
Medical chart information collected at baseline, 12 months, 18 months, 36 months, and 54 months
Duration - One-time interview during the study period
Participants who agree to participate in a one-on-one phone interview share their experiences with symptoms, treatment, and quality of life related to organic acidemia and carglumic acid.
1 phone interview lasting about 1 hour
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
A Burlina, I Bettocchi, G Biasucci...
https://pubmed.ncbi.nlm.nih.gov/35916811/Albina Tummolo, Livio Melpignano, Antonella Carella...
https://pubmed.ncbi.nlm.nih.gov/29679984/Alberto Burlina, Chiara Cazzorla, Elisa Zanonato...
https://pubmed.ncbi.nlm.nih.gov/27489777/Jun Kido, Shirou Matsumoto, Kimitoshi Nakamura
https://pubmed.ncbi.nlm.nih.gov/32231837/Sufin Yap, Delphine Lamireau, Francois Feillet...
https://pubmed.ncbi.nlm.nih.gov/38198106/Majid Alfadhel, Marwan Nashabat, Mohammed Saleh...
https://pubmed.ncbi.nlm.nih.gov/34635114/Ertugrul Kiykim, Ozge Oguz, Cisem Duman...
https://pubmed.ncbi.nlm.nih.gov/33552909/RECORDATI GROUP
Lead Sponsor